Regulation of p53 in response to DNA damage
The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Activation of p53 can occur in response to a number of cellular stresses, including DNA damage, hypoxia and nucleotide deprivation. Several forms of DNA damage have been shown to activate p53, including those generated by ionising radiation (IR), radio-mimetic drugs, ultraviolet light (UV) and chemicals such as methyl methane sulfonate (MMS). Under normal conditions, p53 levels are maintained at a low state by virtue of the extremely short-half life of the polypeptide. In addition to this, p53 normally exists in an largely inactive state that is relatively inefficient at binding to DNA and activating transcription. Activation of p53 in response to DNA damage is associated with a rapid increase in its levels and with an increased ability of p53 to bind DNA and mediate transcriptional activation. This then leads to the activation of a number of genes whose products trigger cell-cycle arrest, apoptosis, or DNA repair. Recent work has suggested that this regulation is brought about largely through DNA damage triggering a series of phosphorylation, de-phosphorylation and acetylation events on the p53 polypeptide. Here, we discuss the nature of these modifications, the enzymes that bring them about, and how changes in p53 modification lead to p53 activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UV-induced phosphorylation at Serine 15 increased p53 stability and protein level that associated with DNA damage [61].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [61]
In the citing paper
“Under normal conditions, cellular p53 protein levels are very low owing to strict control by its negative regulators MDM2 and MDMX, which promote p53 degradation through ubiquitination.27,28”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [28]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 4,296
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 2×
“Interaction of Mdm2 with this N-terminal region of p53 has been demonstrated to inhibit the ability of p53 to activate transcription (Momand et al., 1992; Oliner et al., 1993).”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“Initial clues suggesting that ATM may be involved in regulation of p53 in response to DNA damage came from observations that cell cycle checkpoint controls and up-regulation of p53 in response to IR are defective in A-T cells (Kastan et al., 1992; Khanna and Lavin, 1993; Canman et al., 1994).”
BackgroundHistone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884 · cited 1×
“Further support for this idea has been provided by the demonstration that certain histone acetyl-transferase (HAT) enzymes correspond to key transcriptional coactivators, such as CBP/p300 and PCAF (for reviews see Grunstein, 1997; Kouzarides, 1999).”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785 · cited 1×
“The gene mutated in ataxia-telangiectasia patients was mapped to human chromosome 11q2223, and the gene, termed ATM, has been cloned (Gatti et al., 1988; Savitsky et al., 1995).”
BackgroundActivation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 2×
“Thus, in addition to potentially playing a role in acetylating histones at p53-dependent promoters, CBP/p300 has been shown to be able to acetylate p53 at lysine-373 and lysine-382, whilst PCAF can acetylate p53 at lysine-320 (Gu and Roeder, 1997; Sakaguchi, 1998; Liu et al., 1999).”
BackgroundKo, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344 · cited 4×
“Elevated levels of p21 then inhibit the cyclin E/cdk2 and cyclin A/cdk2 kinases, thus preventing these kinases from promoting cell cycle progression (for review, see Ko and Prives, 1996; Levine, 1997).”
BackgroundInfluential
Research works printed but not linked: 3
- Lakin ND, Hann BC and Jackson SP. . 1999 Oncogene in press.
- Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW. . 1992 Mol. Cell. Biol. 12: 5041–5049. · doi:10.1128/mcb.12.11.5041-5049.1992 · Paper page
- Maltzman W and Czyzyk L. . 1984 Mol. Cell. Biol. 4: 1689–1694. · DOI · Paper page
Cited by
Items 301–400 of 1,000
Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas.
Angèle, S., Treilleux, I., Tanière, P., Martel‐Planche, G., Vuillaume, M., Bailly, C., Bremond, A. G., Montesano, R., & Hall, J. A. (2000) · PubMed · Cited by 64
Zhang, J., Kan, S., Huang, B., Hao, Z., Mak, T. W., & Zhong, Q. (2011) · Genes & Development · doi:10.1101/gad.170605.111 · Cited by 58
Role of primary aging hallmarks in Alzheimer´s disease
Zhao, J., & Huai, J. (2023) · Theranostics · doi:10.7150/thno.79535 · Cited by 51
Zhao, W., Lin, Z. X., & Zhang, Z. (2004) · Cell Research · doi:10.1038/sj.cr.7290203 · Cited by 56
Hebels, D. G. A. J., Sveje, K. M., de Kok, M. C., van Herwijnen, M. H. M., Kuhnle, G., Engels, L. G. J. B., Vleugels-Simon, C. B. E. M., Mares, W. G. N., Pierik, M. J., Masclee, A., et al. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.10.038 · Cited by 55
Tebuconazole induced cardiotoxicity in male adult rat
Othmène, Y. B., Hamdi, H., Annabi, E., Amara, I., Salem, I. B., Neffati, F., Najjar, M. F., & Abid‐Essefi, S. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111134 · Cited by 56
Cadmium Induces Phosphorylation of p53 at Serine 15 in MCF-7 Cells
Matsuoka, M., & Igisu, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4700 · Cited by 57
Biochemical and Molecular Mechanisms of Cisplatin Resistance
Siddik, Z. H. (2002) · Cancer treatment and research · doi:10.1007/978-1-4615-1173-1_13 · Cited by 56
MTA1 Coregulator Regulates p53 Stability and Function
Li, D.-Q., Reddy, S. D. N., Pakala, S. B., Wu, X., Zhang, Y., Rayala, S. K., & Kumar, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056499 · Cited by 57
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
Sonego, M., Schiappacassi, M., Lovisa, S., Dall'Acqua, A., Bagnoli, M., Lovat, F., Libra, M., D'Andrea, S., Canzonieri, V., Militello, L., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201504 · Cited by 52
“The binding of DNA-PK to p53 WT is highly controversial (Lakin & Jackson, 1999).”
Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line
Huang, S., Chang, S.-H., Mu, S.-W., Jiang, H.-Y., Wang, S.-T., Kao, J., Huang, J.-L., Wu, C., Chen, Y., & Shieh, J. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.12.011 · Cited by 58
“In response to DNA damage, the p53 protein is greatly upregulated and activated [31].”
BackgroundParallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance
Bowden, A. R., Morales-Juarez, D. A., Sczaniecka-Clift, M., Agudo, M. M., Lukashchuk, N., Thomas, J. C., & Jackson, S. P. (2020) · eLife · doi:10.7554/elife.55325 · Cited by 56
Self-citationNon-circadian aspects of BHLHE40 cellular function in cancer
Kiss, Z., Mudryj, M. M., & Ghosh, P. (2020) · Genes & Cancer · doi:10.18632/genesandcancer.201 · Cited by 65
“BHLHE40 is regulated by p53, a tumor suppressor that is activated by stress, including DNA damage [113] (Figure 3), and effectively limits cell proliferation that could lead to tumor initiation [114, 115].”
BackgroundLee, Y., Seo, H. W., Baek, J.-H., Lim, S. H., Hwang, S., & Kim, E. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-68473-6 · Cited by 54
Habold, C., Poehlmann, A., Bajbouj, K., Hartig, R., Korkmaz, K., Roessner, A., & Schneider‐Stock, R. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00136.x · Cited by 57
“DNA damage signals are passed to p53 activity through posttranslational modifications such as acetylation of lysine residues [28, 29].”
BackgroundRegulation of the Pancreatic Duodenal Homeobox-1 Protein by DNA-dependent Protein Kinase
Lebrun, P., Montminy, M., & OBBERGHEN, E. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504842200 · Cited by 53
A new effector pathway links ATM kinase with the DNA damage response
Demonacos, C., Krstic–Demonacos, M., Smith, L. M., Xu, D., O’Connor, D. P., Jansson, M., & Thangue, N. B. L. (2004) · Nature Cell Biology · doi:10.1038/ncb1170 · Cited by 65
“The tumour suppressor protein p53 has an important function in the cellular response to DNA damag”
BackgroundATM dependent apoptosis in the nervous system
Lee, Y., & McKinnon, P. J. (2000) · APOPTOSIS · doi:10.1023/a:1009637512917 · Cited by 61
Krause, K., Haugwitz, U., Wasner, M., Wiedmann, M. W., Mössner, J., & Engeland, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5040 · Cited by 61
Cell Death Response to DNA Damage.
Wang, J. Y. J. (2019) · Europe PMC (PubMed Central) · Cited by 86
The emerging relationship between metabolism and DNA repair
Cucchi, D., Gibson, A., & Martin, S. A. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1912889 · Cited by 57
“p53 expression is rapidly increased upon induction of DNA damage or in response to other stresses [38].”
BackgroundFavero, A., Segatto, I., Perin, T., & Belletti, B. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1659 · Cited by 62
“Presence of TP53 mutations correlates with poor prognosis in many cancer types (Kandoth et al., 2013). p53 pathway is activated during normal cellular responses, such as senescence, apoptosis and stress responses, such as DNA damage (Lakin & Jackson, 1999).”
BackgroundThe Role of P53 in Human Cancer
Malkin, D. M. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010636426860 · Cited by 62
“For example, phosphorylation of serines 15, 20, 37, and 392, among others, is induced by various forms of DNA damage including XRT and UV (ultraviolet) light [46].”
BackgroundThe ATR-p53 pathway is suppressed in noncycling normal and malignant lymphocytes
Jones, G. G., Reaper, P. M., Pettitt, A. R., & Sherrington, P. D. (2004) · Oncogene · doi:10.1038/sj.onc.1207318 · Cited by 56
“Serine-15 of p53 is phosphorylated by ATM, following exposure to IR (Canman et al., 1998; Lakin and Jackson, 1999), and by ATR following UVC irradiation (Lakin and Jackson, 1999).”
BackgroundXiong, L., Kou, F., Yang, Y., & Wu, J. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703044 · Cited by 56
“least in part with p53 accumulation (Lakin and Jackson, 1999), we next analyzed the induction of p53 protein levels in R+ and R− MEFs.”
BackgroundInfluentialUrban, G., Golden, T. A., Aragon, I. V., Cowsert, L. M., Cooper, S. R., Dean, N. M., & Honkanen, R. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210993200 · Cited by 56
Cell cycle control, DNA damage checkpoints and cancer
Laiho, M., & Latonen, L. (2003) · Annals of Medicine · doi:10.1080/07853890310014605 · Cited by 59
“The phosphorylations of p53 to multiple sites in damaged cells hinder the binding of MDM2 and thus p53 downregulation, and increase the subsequent p53 transactivation (28, 34).”
Qian, Z., Liu, T., Liu, Q., He, S., Liu, Y., Hou, F., Wang, X., Mi, X., Cai, C., & Liu, X. (2013) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2013.09.009 · Cited by 56
BapE DNA endonuclease induces an apoptotic-like response to DNA damage in Caulobacter
Bos, J., Yakhnina, A. A., & Gitai, Z. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213332109 · Cited by 50
“What do cells do if DNA damage accumulates beyond repair? In animal cells, DNA damage activates a p53-dependent cell cycle checkpoint that stimulates repair in the presence of low levels of damage and induces apoptotic cell death in the presence of high levels of damage (1, 2).”
BackgroundLong, Y., Wu, X., Li, Z., Fan, J., Hu, X., & Liu, B. (2020) · Biomaterials Science · doi:10.1039/d0bm00972e · Cited by 51
Siddik, Z. H. (2005) · Wiley eBooks · doi:10.1002/0470025077.chap84b · Cited by 50
“When DNA is damaged by cisplatin, binding between Mdm2 and p53 is disrupted by phosphorylation of the tumour suppressor and results in p53 induction by virtue of a greater metabolic stability of the free p53 than of the p53–Mdm2 complex (Fritsche et al ., 1993; Shieh et al ., 1997; Lakin and Jackson, 1999).”
BackgroundInfluentialShahabuddin, M. S., Nambiar, M., Choudhary, B., Advirao, G. M., & Raghavan, S. C. (2009) · Investigational New Drugs · doi:10.1007/s10637-008-9212-6 · Cited by 52
“p53 is a transcriptional factor that plays a key role in regulating cell cycle progression, DNA repair and apoptosis [ 34 , 35].”
BackgroundFong, L. Y. Y., Jiang, Y., & Farber, J. L. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl012 · Cited by 51
Gadea, G., Roger, L., Anguille, C., de Toledo, M., Gire, V., & Roux, P. (2004) · Journal of Cell Science · doi:10.1242/jcs.01566 · Cited by 46
“Among these phosphorylation sites, serine 18 in mouse, which corresponds to serine 15 in human p53, is considered as a crucial site that greatly contributes to p53 stabilisation following various genotoxic stresses (Lakin and Jackson, 1999; Tibbetts et al., 1999).”
Backgroundp16INK4a protects against dysfunctional telomere–induced ATR-dependent DNA damage responses
Wang, Y., Sharpless, N., & Chang, S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69574 · Cited by 48
“Figure 6B), suggesting that the p21-dependent cell cycle arrest and elevated apoptosis observed in these cells is primarily due to posttranslational activation of p53 (48).”
Zou, B., Chim, C. S., Pang, R. W. C., Zeng, H., Dai, Y., Zhang, R., Lam, C. S. C., Tan, V. P. Y., Hung, I. F., Lan, H. Y., et al. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20807 · Cited by 50
“The p53 transactivation reporters, including the p53 consensus DNA binding sequence (DBS) (DNA binding site) construct (Lucp53) and the MDM2 promoter luciferase construct (Luc-MDM2), were kindly provided by Dr. Xiongbin Lu from Baylor College of Medicine.”
BackgroundInfluentialCatani, M. V., Costanzo, A., Savini, I., Levrero, M., Laurenzi, V. D., Wang, J. Y. J., Melino, G., & Avigliano, L. (2002) · Biochemical Journal · doi:10.1042/bj20011713 · Cited by 48
Tang, F.-L., Zhao, L., Zhao, Y., Sun, D., Zhu, X.-J., Mei, L., & Xiong, W.-C. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0487-2 · Cited by 47
“As apoptosis can be induced by various cellular stresses, including DNA damage, the P21 control and Vps35 brain sections were immune-stained with antibodies against γH2AX and P53, both DNA damage markers [42, 43].”
BackgroundThe p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression
Fenouille, N., Robert, G., Tichet, M., Puissant, A., Dufies, M., Rocchi, S., Ortonne, J. P., Deckert, M., Ballotti, R., & Tartare‐Deckert, S. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00790.x · Cited by 47
“Given that p53-dependent G2 ⁄ M arrest is a common checkpoint mechanism in response to DNA damage (Lakin and Jackson, 1999), we have analyzed the potential involvement of this pathway upon SPARC silencing.”
BackgroundAbderrazak, A., Hadri, K. E., Bosc, E., Blondeau, B., Slimane, M.-N., Büchele, B., Simmet, T., Couchie, D., & Rouis, M. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232934 · Cited by 51
“The mechanism of autophagy-mediated effects on the Bcl2 could be related to the autophagic clearance of cells from damaged DNA, which is known to activate p53 (Lakin and Jackson, 1999) and to induce its expression via Nrf2 (Filomeni et al.”
BackgroundDisruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression
Lucchesi, C. A., Zhang, J., Ma, B., Chen, M., & Chen, X. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-2209 · Cited by 48
“Pep8 sensitizes tumor cells to doxorubicin It is widely accepted that DNA damage, including treatment with doxorubicin, induces p53 protein accumulation through multiple posttranslational modifications (38).”
BackgroundNorcantharidin-Induced Post-G2/M Apoptosis Is Dependent on Wild-Type p53 Gene
Hong, C., Huang, S. C., Lin, S., Lee, J. J., Chueh, L.-L., Lee, C.-H. K., Lin, J.-H., & Hsiao, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3341 · Cited by 47
Lung, M. L., Dai, W., & Ko, J. M. Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814936-2.00002-x · Cited by 46
Cell Cycle and Senescence Regulation by Podocyte Histone Deacetylase 1 and 2
Rangel, P. X. M., Cross, E., Liu, C., Pedigo, C. E., Tian, X., Gutiérrez-Calabrés, E., Nagata, S., Priyadarshini, A., Lerner, G., Bunda, P., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022050598 · Cited by 48
The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy
Damasio, M. P. S., Nascimento, C. S., de Andrade, L. M., de Oliveira, V. L., & Calzavara-Silva, C. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1021609 · Cited by 48
“P53 levels increase due to DNA damage, nucleotide deprivation and hypoxia (87).”
BackgroundGarate, M., Campos, E. I., Bush, J., Xiao, H., & Li, G. (2007) · The FASEB Journal · doi:10.1096/fj.07-8069com · Cited by 59
Rigatti, M. J., Verma, R., Belinsky, G. S., Rosenberg, D. W., & Giardina, C. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.20795 · Cited by 45
Pan, S., Li, C.-Y., Kuo, C.-Y., Kuo, Y.-Z., Fang, W., Huang, Y., Hsieh, T.-C., Kao, H., Kuo, Y., Kang, Y.-R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23697-5 · Cited by 47
“We concluded that the ability of S100A2 to potentiate p53 activity occurs at two levels: (1) S100A2 increases p53 protein expression by inducing its mRNA accumulation and (2) S100A2 potentiates p53 transcriptional activity through its physical interaction.”
BackgroundA matter of concern – Trace element dyshomeostasis and genomic stability in neurons
Wandt, V. K., Winkelbeiner, N., Bornhorst, J., Witt, B., Raschke, S., Simon, L., Ebert, F., Kipp, A. P., & Schwerdtle, T. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101877 · Cited by 45
“Prominently involved in exerting these tasks is the tumour suppressor protein p53, the so-called “guardian of the genome” [24].”
BackgroundMelatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders
Loh, D., & Reiter, R. J. (2021) · Antioxidants · doi:10.3390/antiox10091483 · Cited by 46
Fritz, G., Brachetti, C., & Kaina, B. (2003) · International Journal of Radiation Biology · doi:10.1080/09553000310001609233 · Cited by 52
“For example, c-Fos2/2, p652/2 and p532/2 cells are hypersensitive to UV light or c-rays (Wang et al. 1996, Kaina et al. 1997, Lakin and Jackson 1999, Shaulian et al. 2000).”
BackgroundPluquet, O., North, S., Bhoumik, A., DIMAS, K. S., Ronai, Z. A., & Hainaut, P. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207396200 · Cited by 50
Viola, G., Fortunato, E., Cecconet, L., del Giudice, L., Dall’Acqua, F., & Basso, G. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.10.004 · Cited by 48
Huang, Y., Tan, M., Gosink, M. M., Wang, K., & Sun, Y. (2002) · PubMed · Cited by 57
Hockley, S. L., Arlt, V. M., Jahnke, G., Hartwig, A., Giddings, I., & Phillips, D. H. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm227 · Cited by 46
“Upon genotoxic stress, cellular levels of p53 protein increase via post-transcriptional mechanisms [2] and the ability of p53 to bind specific DNA sequences is activated.”
BackgroundInfluentialBesnard, V., Corroyer, S., Trugnan, G., Chadelat, K., Nabeyrat, E., Cazals, V., & Clément, A. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00136-1 · Cited by 45
Cellular senescence is increased in airway smooth muscle cells of elderly persons with asthma
Aghali, A., Khalfaoui, L., Lagnado, A. B., Drake, L. Y., Teske, J. J., Pabelick, C. M., Passos, J. F., & Prakash, Y. S. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00146.2022 · Cited by 44
Peng, X., Bai, S., Ding, X., Zeng, Q., Zhang, K., & Fang, J. S. (2015) · Avian Pathology · doi:10.1080/03079457.2015.1023179 · Cited by 44
“P53-related genes are activated by DNA damage (Lakin & Jackson, 1999).”
BackgroundZhang, R., Wang, Y., Li, J., Jin, H., Song, S., & Huang, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.513960 · Cited by 44
“p53, a sensitive DNA damage-responsive transcriptional factor, is always up-regulated in cellular response to DNA damage treatments (32, 33).”
BackgroundHaneef, J., Parvathy, M., Santhosh Kumar Thankayyan, R., Sithul, H., & Sreeja, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040055 · Cited by 45
“Defects in cell cycle is a notable feature of many cancer cells allowing it to proliferate uncontrollably whereas in normal cells, cell cycle progression is regulated by cell cycle check points [35].”
BackgroundWang, Y., Debatin, K., & Hug, H. (2001) · BMC Molecular Biology · doi:10.1186/1471-2199-2-8 · Cited by 53
“The nuclear phosphoprotein p53 is regulated and stabilized by different modifications [3,18], e.”
BackgroundJayaraman, S., Chittiboyina, S., Bai, Y., Abad, P. C., Vidi, P., Stauffacher, C. V., & Lelièvre, S. A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx782 · Cited by 43
“In vitro studies have shown that p53 levels are enhanced in cells sustaining DNA damage (92).”
BackgroundSelenium modulates inorganic mercury induced cytotoxicity and intrinsic apoptosis in PC12 cells
Hossain, K. F. B., Rahman, M. M., Sikder, M. T., Hosokawa, T., Saito, T., & Kurasaki, M. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111262 · Cited by 43
Genetic interactions between Pten and p53 in radiation-induced lymphoma development
Mao, J., Wu, D., Pérez‐Losada, J., Nagase, H., Delrosario, R., & Balmain, A. (2003) · Oncogene · doi:10.1038/sj.onc.1207083 · Cited by 46
“The p53 tumor suppressor gene controls cellular responses to DNA damage and forms a critical link to downstream effectors of growth arrest or cell death (Agarwal et al., 1998; el-Deiry, 1998; Lakin and Jackson, 1999; Caspari, 2000).”
BackgroundAndrographolide Induces Apoptosis of C6 Glioma Cells via the ERK-p53-Caspase 7-PARP Pathway
Yang, S., Wang, S., Syu, J.-P., Chen, Y., Wang, S., Peng, Y., Kuo, M., & Kung, H. (2014) · BioMed Research International · doi:10.1155/2014/312847 · Cited by 44
“p53 is characterized as a stressresponse protein, which is induced by DNA damage [55], oxidative stress [56], and deregulated oncogene expression [40].”
BackgroundRôle du zinc intracellulaire dans la mort cellulaire programmée
Seve, M., Chimienti, F., & Favier, A. E. (2002) · Pathologie Biologie · doi:10.1016/s0369-8114(02)00290-0 · Cited by 43
TP53 ‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management
Shah, M. V., Arber, D. A., & Hiwase, D. (2025) · American Journal of Hematology · doi:10.1002/ajh.27655 · Cited by 46
“Response to cytotoxic chem-otherapies is highly dependent on the presence of intact p53 to enable the induction of apoptosis [107, 108].”
Sousounis, K., Bryant, D. M., Fernandez, J. M., Eddy, S. S., Tsai, S. L., Gundberg, G. C., Han, J., Courtemanche, K., Levin, M. G., & Whited, J. L. (2020) · eLife · doi:10.7554/elife.51217 · Cited by 44
Talebi, M., Talebi, M., Kakouri, E., Farkhondeh, T., Pourbagher‐Shahri, A. M., Tarantilis, P. Α., & Samarghandian, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.042 · Cited by 46
p53 Isoforms as Cancer Biomarkers and Therapeutic Targets
Zhao, L., & Sanyal, S. (2022) · Cancers · doi:10.3390/cancers14133145 · Cited by 44
Boutell, C., & Everett, R. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8068-8077.2004 · Cited by 47
Modulation von Protein‐Protein‐Wechselwirkungen mit niedermolekularen organischen Molekülen
Berg, T. (2003) · Angewandte Chemie · doi:10.1002/ange.200200558 · Cited by 41
Targeting senescence pathways to reverse drug resistance in cancer
Rebbaa, A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.08.011 · Cited by 42
“[14] N.”
BackgroundAndo, K., Higami, Y., Tsuchiya, T., Kanematsu, T., & Shimokawa, I. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10207 · Cited by 41
Wang, Y., Cheng, X., Wang, P., Wang, L., Fan, J., Wang, X., & Liu, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101303 · Cited by 44
“It is also widely recognized DNA damage could provoke the increase of P53 level to induce arrest within the G1 and G2 phase of the cell cycle, apoptosis, and DNA repair [32,33].”
BackgroundChronic irradiation of human cells reduces histone levels and deregulates gene expression
Lowe, D., Herzog, M., Mosler, T., Cohen, H., Felton, S. J., Beli, P., Raj, K., Galanty, Y., & Jackson, S. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-59163-4 · Cited by 44
Self-citationTemprine, K., Campbell, N. R., Huang, T. H., Langdon, E. M., Simon-Vermot, T., Mehta, K., Clapp, A., Chipman, M. E., & White, R. M. (2020) · Science Signaling · doi:10.1126/scisignal.aau1453 · Cited by 38
“We also tested whether knockdown of p53, which is a regulator of the DNA damage response pathway (49), would prevent the observed subcellular shift but failed to see any change in the nuclear localization of Pol after treatment with PLX4032 (fig.”
BackgroundSIRT1 inhibitors mitigate radiation-induced GI syndrome by enhancing intestinal-stem-cell survival
Fu, G., Chen, S., Liang, L., Li, X., Tang, P., Rao, X., Pan, M., Xu, X., Li, Y., Yao, Y., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.12.034 · Cited by 40
TRPML1-induced autophagy inhibition triggers mitochondrial mediated apoptosis
Liu, Y., Wang, X., Zhu, W., Sui, Z., Wei, X., Zhang, Y., Qi, J., Xing, Y., & Wang, W. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215752 · Cited by 43
Rana, J. N., Mumtaz, S., Choi, E. H., & Han, I. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1067861 · Cited by 40
“Following that, several genes that produce apoptosis, DNA repair, or cell-cycle arrest are activated (Lakin and Jackson, 1999).”
BackgroundTsai, M.-H., Chen, X., Chandramouli, G., Chen, Y.-W., Yan, H., Zhao, S., Keng, P. C., Liber, H. L., Coleman, C. N., Mitchell, J. B., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209082 · Cited by 40
“Ionizing radiation induces damage to DNA, and this is followed by a variety of cellular responses such as cellcycle arrest, transformation, and cell death (Lakin and Jackson, 1999; Gong and Almasan, 2000; Backlund et al., 2001).”
BackgroundAi, T.-J., Sun, J., Du, L., Shi, C., Li, C., Sun, X., Liu, Y., Li, L., Xia, Z., Jia, L., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.160 · Cited by 40
Heavy‐ion‐induced mutations in the gpt delta transgenic mouse: Effect of p53 gene knockout
Yatagai, F., Kurobe, T., Nohmi, T., Masumura, K., Tsukada, T., Yamaguchi, H., Kasai‐Eguchi, K., & Fukunishi, N. (2002) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10107 · Cited by 40
“The tumor suppressor gene p53 is known to be involved in various radiation defense mechanisms, including signal transduction, cell cycle checkpoint control, apoptosis, and DNA repair [Lakin and Jackson, 1999].”
BackgroundZhang, M., Li, J., Xing, G., He, R., Li, W., Song, Y. L., & Guo, H. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0725-y · Cited by 42
“Under normal conditions, the cellular content of p53 is kept by means of ubiquitin-mediated degradation (Lakin and Jackson 1999).”
BackgroundNovel Insights into the Molecular Mechanisms Governing Mdm2 Ubiquitination and Destruction
Inuzuka, H., Fukushima, H., Shaik, S., & Wei, W. (2010) · Oncotarget · doi:10.18632/oncotarget.202 · Cited by 40
“Different types of DNA damage signals and variations in the extent of DNA-damage triggers activation of a distinct set of p53 downstream targets, thus initiating different types of stress response [9].”
BackgroundDNA: Damage and Repair Mechanisms in Humans
Ambekar, S. S. (2017) · Global Journal of Pharmacy & Pharmaceutical Sciences · doi:10.19080/gjpps.2017.03.555613 · Cited by 44
“This in turn leads to ketosis, hyperlipidism, increased fat storage and metabolic syndrome [19-22].”
BackgroundDreyfus, D. H., Nagasawa, M., Gelfand, E. W., & Ghoda, L. Y. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-12 · Cited by 40
“These observations suggest p53 and related proteins function as a checkpoint for malignant transformation either by repairing DNA damage or by eliminating cells with irreparably damaged DNA [6-8]”
BackgroundChristmann, M., Tomicic, M. T., Origer, J., & Kaina, B. (2005) · Oncogene · doi:10.1038/sj.onc.1208994 · Cited by 41
“This results in increased nuclear translocation of p53, enhanced DNA binding and transcriptional activity of target genes (Lakin and Jackson, 1999).”
BackgroundKanemitsu, H., Yamauchi, H., Komatsu, M., Yamamoto, S., Okazaki, S., Uchida, K., & Nakayama, H. (2008) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2008.10.001 · Cited by 41
Williams, R., & Hubberstey, A. V. (2014) · Aquatic Toxicology · doi:10.1016/j.aquatox.2014.09.001 · Cited by 39
Role of SHP-2 Tyrosine Phosphatase in the DNA Damage-induced Cell Death Response
Yuan, L., Yu, W., Yuan, Z.-M., Haudenschild, C. C., & Qu, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211327200 · Cited by 42
Liu, X., Happel, C., & Ziegelbauer, J. M. (2016) · Journal of Virology · doi:10.1128/jvi.02045-16 · Cited by 42
“One important cellular factor activated in the context of DNA damage is p53 (37).”
BackgroundP53-responsive genes and the potential for cancer diagnostics and therapeutics development
Xu, H. Y., & El-Gewely, M. R. (2001) · Biotechnology annual review · doi:10.1016/s1387-2656(01)07035-1 · Cited by 42
Nucleolin is involved in interferon regulatory factor-2-dependent transcriptional activation
Masumi, A., Fukazawa, H., Shimazu, T., Yoshida, M., Ozato, K., Komuro, K., & Yamaguchi, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209522 · Cited by 40
“…Tat and CTIIA regulate specific promoters associated with the coactivators p300 and p300/CBPassociated factor (PCAF), and that this regulation leads to specific biological functions (Lakin and Jackson, 1999; Deng et al., 2000; Spilianakis et al., 2000; Polwsskaya et al., 2001; Wolf et al., 2002).”
BackgroundOhno, K., Tanaka-Azuma, Y., Yoneda, Y., & Yamada, T. (2005) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2005.09.002 · Cited by 39
Prolonged Wild-Type p53 Protein Accumulation and Cisplatin Resistance
Yazlovitskaya, E. M., DeHaan, R. D., & Persons, D. L. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4849 · Cited by 39
Hu, V. W., Heikka, D. S., Dieffenbach, P. B., & Ha, U. (2001) · The FASEB Journal · doi:10.1096/fj.01-0102com · Cited by 39
“Cell cycle arrest is most obvious in cultures of radiolabeled synchronized cells that fail to divide within their normal division cycle and has been attributed, in at least two cases, to increases in the level of p53 (3, 4), a major cell cycle checkpoint regulator that serves as a molecular sensor for DNA damage (7).”
BackgroundAttias-Geva, Z., Bentov, I., Kidron, D., Amichay, K., Sarfstein, R., Fishman, A., Bruchim, I., & Werner, H. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.09.014 · Cited by 40
Preya, U. H., Lee, K., Kim, N., Lee, J., Jang, D. S., & Choi, J. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.05.011 · Cited by 40
Mad1 destabilizes p53 by preventing PML from sequestering MDM2
Wan, J., Block, S., Scribano, C. M., Thiry, R., Esbona, K., Audhya, A., & Weaver, B. A. A. (2019) · Nature Communications · doi:10.1038/s41467-019-09471-9 · Cited by 43
“Mad1(1-596) -3XFLAG + HA-PML DAPI FLAG HA DAPI FLAG HA C on tr ol M ad 13x F LA G”
Background
Metadata
- Authors
- Lakin, N. D., & Jackson, S. P.
- Affiliations
- University of Cambridge (GB)
- ORCID
- Jackson, Stephen P
- Venue
- Oncogene
- Published
- 1999-12-13
- Volume
- 18
- Issue
- 53
- Pages
- 7644-7655
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2007935491
- Cited by
- 987
- References
- 128
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 30 · 2023: 54 · 2022: 57 · 2021: 46 · 2020: 46 · 2019: 33 · 2018: 40 · 2017: 43 · 2016: 34 · 2015: 33 · 2014: 28 · 2013: 23 · 2012: 28
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, DNA damage response, p53 activation, post-translational modification, phosphorylation, dephosphorylation, acetylation, ionizing radiation, ultraviolet radiation, methyl methanesulfonate, cell cycle arrest, apoptosis, DNA repair, transcriptional activation, hypoxia
- MeSH terms
- Adenosine Triphosphatases, Animals, DNA Damage, DNA Helicases, DNA-Binding Proteins, Humans, Nuclear Proteins, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Signal Transduction, Trans-Activators, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, Saccharomyces cerevisiae Proteins, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.